Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies.
Perruccio K, Sisinni L, Perez-Martinez A, Valentin J, Capolsini I, Massei MS, Caniglia M, Cesaro S. Perruccio K, et al. Among authors: valentin j. Biol Blood Marrow Transplant. 2018 Dec;24(12):2549-2557. doi: 10.1016/j.bbmt.2018.07.033. Epub 2018 Jul 29. Biol Blood Marrow Transplant. 2018. PMID: 30067953 Free article.
Donor KIR Genotype Impacts on Clinical Outcome after T Cell-Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients.
Escudero A, Martínez-Romera I, Fernández L, Valentín J, González-Vicent M, Vicario JL, Madero-Jarabo R, Diaz MÁ, Pérez-Martínez A. Escudero A, et al. Among authors: valentin j. Biol Blood Marrow Transplant. 2018 Dec;24(12):2493-2500. doi: 10.1016/j.bbmt.2018.08.009. Epub 2018 Aug 24. Biol Blood Marrow Transplant. 2018. PMID: 30145228 Free article.
Influence of a Moderate-Intensity Exercise Program on Early NK Cell Immune Recovery in Pediatric Patients After Reduced-Intensity Hematopoietic Stem Cell Transplantation.
Chamorro-Viña C, Valentín J, Fernández L, González-Vicent M, Pérez-Ruiz M, Lucía A, Culos-Reed SN, Díaz MÁ, Pérez-Martínez A. Chamorro-Viña C, et al. Among authors: valentin j. Integr Cancer Ther. 2017 Dec;16(4):464-472. doi: 10.1177/1534735416679515. Epub 2016 Nov 30. Integr Cancer Ther. 2017. PMID: 27903841 Free PMC article.
Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantation.
Vela M, Del Rosal T, Pérez-Martínez A, Valentín J, Casas I, Pozo F, Reinoso-Barbero F, Bueno D, Corral D, Méndez-Echevarría A, Mozo Y, Calvo C. Vela M, et al. Among authors: valentin j. Sci Rep. 2019 Dec 11;9(1):18792. doi: 10.1038/s41598-019-55398-y. Sci Rep. 2019. PMID: 31827202 Free PMC article.
A phase I/II trial of interleukin-15--stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors.
Pérez-Martínez A, Fernández L, Valentín J, Martínez-Romera I, Corral MD, Ramírez M, Abad L, Santamaría S, González-Vicent M, Sirvent S, Sevilla J, Vicario JL, de Prada I, Diaz MÁ. Pérez-Martínez A, et al. Among authors: valentin j. Cytotherapy. 2015 Nov;17(11):1594-603. doi: 10.1016/j.jcyt.2015.07.011. Epub 2015 Sep 1. Cytotherapy. 2015. PMID: 26341478 Clinical Trial.
Natural killer cells can exert a graft-vs-tumor effect in haploidentical stem cell transplantation for pediatric solid tumors.
Pérez-Martínez A, de Prada Vicente I, Fernández L, González-Vicent M, Valentín J, Martín R, Maxwell H, Sevilla J, Vicario JL, Díaz MÁ. Pérez-Martínez A, et al. Among authors: valentin j. Exp Hematol. 2012 Nov;40(11):882-891.e1. doi: 10.1016/j.exphem.2012.07.004. Epub 2012 Jul 4. Exp Hematol. 2012. PMID: 22771496 Free article.
Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia.
Vela M, Corral D, Carrasco P, Fernández L, Valentín J, González B, Escudero A, Balas A, de Paz R, Torres J, Leivas A, Martinez-Lopez J, Pérez-Martínez A. Vela M, et al. Among authors: valentin j. Cancer Lett. 2018 May 28;422:107-117. doi: 10.1016/j.canlet.2018.02.033. Epub 2018 Feb 23. Cancer Lett. 2018. PMID: 29477379 Clinical Trial.
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?
Fernández L, Leivas A, Valentín J, Escudero A, Corral D, de Paz R, Vela M, Bueno D, Rodríguez R, Torres JM, Díaz-Almirón M, López-Collazo E, Martinez-Lopez J, Pérez-Martínez A. Fernández L, et al. Among authors: valentin j. Transfusion. 2018 Jun;58(6):1340-1347. doi: 10.1111/trf.14573. Epub 2018 Mar 14. Transfusion. 2018. PMID: 29542132
543 results